Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > It is not just VM
View:
Post by postie1 on Aug 21, 2023 8:51pm

It is not just VM

Here is a link that will show youhow badly new lows are outpacing new highs. So are people dumping to cover? Are people just in a panic? This is painful but I am not going to sell unless there is no other choice but that is just my choice. Make up your own mindfor yourselves.

Summary of Stocks With New Highs & Lows - Barchart.com
Comment by postie1 on Aug 21, 2023 8:55pm
You can also do Canada if you click on the arrow next to the American flag and a list of countries will come up
Comment by whitenorth72 on Aug 22, 2023 12:24pm
Well, I'm still picking up some shares at this price. anything under .065 feels right. Good luck all
Comment by postie1 on Aug 22, 2023 3:19pm
I see a couple of the boys on the other site are doing the same. Would give you 2 thumbs up but I can't
Comment by biggdogg on Aug 23, 2023 3:18pm
Anyone hearing anything about thier pending financing? When the company goes silent, there tends to be something in the works that will be good. 
Comment by biggdogg on Aug 23, 2023 3:21pm
Silence = Blackout=Significant event, 
Comment by lscfa on Aug 23, 2023 4:06pm
People that participated in Dec/Jan pp are still pissed. Good luck doing another pp.
Comment by biggdogg on Aug 23, 2023 5:27pm
Absolutely, I completely agree with your perspective. Presently, many investors are feeling frustrated, resulting in the sale of their VM shares at substantial losses. The reasons behind this trend remain unclear, as Voy has accomplish so much since going public in 2017, and receiving zero value for all that has been accomplished.   VM's declining value despite years of progress ...more  
Comment by lscfa on Aug 23, 2023 8:29pm
$250,000 of the proceeds from the Dec/Jan pp were suppose to be for "SmoothX & Corporate Marketing" suggesting revenues would commence. So what the hell is the delay?
Comment by Finnexas on Aug 23, 2023 11:38pm
Couldn't Agree more! Always promises of revenue no results
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1